Gauvreau, Gail M <br/><br/>
The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma.  [electronic resource] 

 -  The Journal of allergy and clinical immunology  Aug 2003 
 - 331-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0091-6749 
<br/><br/><label>Standard No.: </label>10.1067/mai.2003.1689  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Asthma--complications<br/>Blood Proteins--metabolism<br/>Bronchial Hyperreactivity--drug therapy<br/>Bronchitis--drug therapy<br/>CD11a Antigen--immunology<br/>Double-Blind Method<br/>Eosinophil Granule Proteins<br/>Female<br/>Forced Expiratory Volume--drug effects<br/>Humans<br/>Hypersensitivity--complications<br/>Male<br/>Middle Aged<br/>Ribonucleases<br/>Sputum--cytology